Media Summary: WebMD's Chief Medical Officer, John Whyte, MD, speaks with George Yancopoulos, MD, PhD, President & Chief Scientific Officer, ... The FDA granted emergency use authorization for the treatment back in November. For over 30 years, our mission has been to use the power of science to bring new medicines to patients…over and over again.
Regeneron Co Founder On Monoclonal - Detailed Analysis & Overview
WebMD's Chief Medical Officer, John Whyte, MD, speaks with George Yancopoulos, MD, PhD, President & Chief Scientific Officer, ... The FDA granted emergency use authorization for the treatment back in November. For over 30 years, our mission has been to use the power of science to bring new medicines to patients…over and over again. ... and things are going really well,” Dr. George Yancopoulos, CNBC's Meg Tirrell joins 'The News with Shepard Smith' to discuss the
